isoproterenol has been researched along with Cardiovascular Diseases in 51 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cardiac fibrosis is a common cause of most cardiovascular diseases." | 5.72 | Leonurine inhibits cardiomyocyte pyroptosis to attenuate cardiac fibrosis via the TGF-β/Smad2 signalling pathway. ( Chen, K; Li, Z; Zhu, YZ, 2022) |
| "Cardiac fibrosis is a common feature of many cardiac pathophysiologic conditions." | 5.48 | Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome. ( Qi, R; Tuerdi, N; Wan, Y; Wang, Y; Xu, L; Ye, M, 2018) |
| " This study was conducted to assess the cardioprotective action of TPN against isoproterenol (ISO)-induced cardiotoxicity." | 4.12 | Alpha-terpineol prevents myocardial damage against isoproterenol-MI induced in Wistar-Kyoto rats: new possible to promote cardiovascular integrity. ( Bernardino, AC; de Oliveira, KRV; Machado, MLDP; Oliveira, AP; Paulino, ET; Quintans-Júnior, LJ; Ribeiro, ÊAN; Rodrigues, AKBF, 2022) |
| "Lead is considered a causative factor for hypertension and other cardiovascular diseases." | 3.85 | Sub-chronic lead exposure produces β ( Alonso, MJ; Fioresi, M; Salaices, M; Simões, MR; Toscano, CM; Vassallo, DV, 2017) |
| " Our primary aim was to investigate βAR-mediated inflammation control (BARIC) responses of blood monocytes to isoproterenol (Iso) in relation to BP and CVD risk factors, including obesity, depressive mood, fasting glucose, triglycerides, and cholesterol levels in the 64 prehypertensive compared to 84 individuals with normal BP." | 3.81 | Beta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular disease. ( Cheng, T; Dimitrov, S; Green, JM; Hong, S; Mills, PJ; Pruitt, C; Redwine, L; Shaikh, F; Wilson, K; Ziegler, MG, 2015) |
| " We studied the response to acute isoproterenol in SUR2 null mice as a model of acute adrenergic stress and found that the episodic coronary vasospasm observed at baseline in SUR2 null mice was alleviated." | 3.74 | Mice lacking sulfonylurea receptor 2 (SUR2) ATP-sensitive potassium channels are resistant to acute cardiovascular stress. ( Chalupsky, K; Earley, JU; Kakkar, R; Makielski, JC; McNally, EM; Shi, NQ; Smelley, M; Stoller, D, 2007) |
| "Cardiac fibrosis is a common cause of most cardiovascular diseases." | 1.72 | Leonurine inhibits cardiomyocyte pyroptosis to attenuate cardiac fibrosis via the TGF-β/Smad2 signalling pathway. ( Chen, K; Li, Z; Zhu, YZ, 2022) |
| "Control of hyperlipidemia is believed to reduce major cardiovascular events such as cardiovascular death, myocardial infarction, nonfatal stroke, hospitalization for unstable angina, and coronary revascularization." | 1.72 | The effect of bempedoic acid an ATP-citrate lyase inhibitor on cardiovascular risk factors in rats with experimentally induced myocardial infarction and hyperlipidemia. ( Mohammed Ali, N; Yaseen, MS, 2022) |
| "Cardiac fibrosis is a common feature of many cardiac pathophysiologic conditions." | 1.48 | Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome. ( Qi, R; Tuerdi, N; Wan, Y; Wang, Y; Xu, L; Ye, M, 2018) |
| " The average plasma half-life of ISO was 4." | 1.29 | The pharmacokinetics of isoproterenol in critically ill pediatric patients. ( Eldadah, MK; Newth, CJ; Reyes, G; Schwartz, PH, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (60.78) | 18.7374 |
| 1990's | 2 (3.92) | 18.2507 |
| 2000's | 3 (5.88) | 29.6817 |
| 2010's | 9 (17.65) | 24.3611 |
| 2020's | 6 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bernak-Oliveira, Â | 1 |
| Guizoni, DM | 1 |
| Chiavegatto, S | 1 |
| Davel, AP | 1 |
| Rossoni, LV | 1 |
| Paulino, ET | 1 |
| Rodrigues, AKBF | 1 |
| Machado, MLDP | 1 |
| de Oliveira, KRV | 1 |
| Bernardino, AC | 1 |
| Quintans-Júnior, LJ | 1 |
| Oliveira, AP | 1 |
| Ribeiro, ÊAN | 1 |
| Li, Z | 1 |
| Chen, K | 1 |
| Zhu, YZ | 1 |
| Baburina, Y | 1 |
| Krestinin, R | 1 |
| Fedorov, D | 1 |
| Odinokova, I | 1 |
| Pershina, E | 1 |
| Sotnikova, L | 1 |
| Krestinina, O | 1 |
| Yaseen, MS | 1 |
| Mohammed Ali, N | 1 |
| Palanisamy, S | 1 |
| Xue, C | 1 |
| Ishiyama, S | 1 |
| Naga Prasad, SV | 1 |
| Gabrielson, K | 1 |
| Toscano, CM | 1 |
| Simões, MR | 1 |
| Alonso, MJ | 1 |
| Salaices, M | 1 |
| Vassallo, DV | 1 |
| Fioresi, M | 1 |
| Rydén, M | 1 |
| Arner, P | 1 |
| Wan, Y | 1 |
| Xu, L | 1 |
| Wang, Y | 1 |
| Tuerdi, N | 1 |
| Ye, M | 1 |
| Qi, R | 1 |
| Yuan, YH | 1 |
| Zheng, XM | 1 |
| He, XH | 1 |
| Liu, LP | 1 |
| Xu, W | 1 |
| Xia, XH | 1 |
| Luo, JH | 1 |
| Lyu, M | 1 |
| Zhu, QL | 1 |
| Wang, S | 1 |
| Wu, S | 1 |
| Zhao, WB | 1 |
| Lu, Q | 1 |
| Nguyen, MN | 1 |
| Su, Y | 1 |
| Ziemann, M | 1 |
| Wang, LN | 1 |
| Kiriazis, H | 1 |
| Puthalakath, H | 1 |
| Sadoshima, J | 1 |
| Hu, HY | 1 |
| Du, XJ | 1 |
| Hong, S | 1 |
| Dimitrov, S | 1 |
| Cheng, T | 1 |
| Redwine, L | 1 |
| Pruitt, C | 1 |
| Mills, PJ | 2 |
| Ziegler, MG | 3 |
| Green, JM | 1 |
| Shaikh, F | 1 |
| Wilson, K | 1 |
| Yeung, PK | 1 |
| Kolathuru, SS | 1 |
| Agu, RU | 1 |
| Shahat, AA | 1 |
| Alsaid, MS | 1 |
| Rafatullah, S | 1 |
| Al-Sohaibani, MO | 1 |
| Parvez, MK | 1 |
| Al-Dosari, MS | 1 |
| Exarchou, V | 1 |
| Pieters, L | 1 |
| Euteneuer, F | 1 |
| Rief, W | 1 |
| Dimsdale, JE | 2 |
| CHANDLER, D | 1 |
| ROSENBAUM, J | 1 |
| NICKEL, SN | 1 |
| THIBAUDEAU, Y | 1 |
| BECKER, DJ | 1 |
| NONKIN, PM | 1 |
| BENNET, LD | 1 |
| KIMBALL, SG | 1 |
| STERNBERG, MS | 1 |
| WASSERMAN, F | 1 |
| HANDFORTH, CP | 1 |
| IWA, T | 1 |
| KAMATA, K | 1 |
| ENDO, K | 1 |
| ALTMAN, KA | 1 |
| SCHAUB, F | 1 |
| DUSEK, J | 1 |
| JEZDINSKA, V | 1 |
| CLARK, DT | 1 |
| Lavi, S | 1 |
| Aharon-Peretz, J | 1 |
| Haim, N | 1 |
| Vlodavsky, E | 1 |
| Jacob, G | 1 |
| Stoller, D | 1 |
| Kakkar, R | 1 |
| Smelley, M | 1 |
| Chalupsky, K | 1 |
| Earley, JU | 1 |
| Shi, NQ | 1 |
| Makielski, JC | 1 |
| McNally, EM | 1 |
| Ceylan-Isik, A | 1 |
| Hünkar, T | 1 |
| Aşan, E | 1 |
| Kaymaz, F | 1 |
| Ari, N | 1 |
| Söylemezoğlu, T | 1 |
| Renda, N | 1 |
| Soncul, H | 1 |
| Bali, M | 1 |
| Karasu, C | 1 |
| Stiles, GL | 1 |
| Caron, MG | 1 |
| Lefkowitz, RJ | 1 |
| Zaritsky, A | 1 |
| Chernow, B | 1 |
| Watkins, LL | 1 |
| Reyes, G | 1 |
| Schwartz, PH | 1 |
| Newth, CJ | 1 |
| Eldadah, MK | 1 |
| Hollander, W | 1 |
| Prusty, S | 1 |
| Kirkpatrick, B | 1 |
| Paddock, J | 1 |
| Nagraj, S | 1 |
| Guntheroth, W | 1 |
| Cartier, F | 1 |
| Chevet, D | 1 |
| Garré, M | 1 |
| Launois, B | 1 |
| Thomas, R | 1 |
| Le Pollès, R | 1 |
| Hysmith, RH | 1 |
| Welch, TK | 1 |
| Boor, PJ | 1 |
| Krikler, D | 1 |
| Vatner, SF | 1 |
| Patrick, TA | 1 |
| Deptalla, H | 1 |
| Wiegershausen, B | 1 |
| Bekes, M | 1 |
| Matos, L | 1 |
| Rausch, J | 1 |
| Török, E | 1 |
| Obtulowicz, K | 1 |
| Król, W | 1 |
| Leon, L | 1 |
| Cabrol, A | 1 |
| Cabrol, C | 1 |
| Luciani, J | 1 |
| Chapelle, M | 1 |
| Guiraudon, G | 1 |
| Rothlin, M | 1 |
| Dornhorst, AC | 1 |
| Harrison, DC | 1 |
| Kerber, RE | 1 |
| Alderman, EL | 1 |
| Enrico, JF | 1 |
| Perret, C | 1 |
| Wada, M | 1 |
| Davis, JN | 1 |
| Frohlich, ED | 2 |
| Tarazi, RC | 2 |
| Dustan, HP | 2 |
4 reviews available for isoproterenol and Cardiovascular Diseases
| Article | Year |
|---|---|
GPCR-ErbB transactivation pathways and clinical implications.
Topics: Animals; Cardiovascular Diseases; ErbB Receptors; Humans; Isoproterenol; Matrix Metalloproteinase 14 | 2021 |
Beta-adrenergic receptors: biochemical mechanisms of physiological regulation.
Topics: Adenylyl Cyclases; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; A | 1984 |
Use of catecholamines in pediatrics.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Pressure; Cardiovascular Diseases; | 1984 |
[Beta-receptor-blocking agents and their current clinical significance].
Topics: Adrenal Gland Neoplasms; Amino Alcohols; Angina Pectoris; Anilides; Arrhythmias, Cardiac; Blood Pres | 1968 |
1 trial available for isoproterenol and Cardiovascular Diseases
| Article | Year |
|---|---|
Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness.
Topics: Adult; Autonomic Nervous System; Blood Circulation; Blood Pressure; Cardiac Output; Cardiovascular D | 1969 |
46 other studies available for isoproterenol and Cardiovascular Diseases
| Article | Year |
|---|---|
The protective role of neuronal nitric oxide synthase in endothelial vasodilation in chronic β-adrenoceptor overstimulation.
Topics: Adrenergic beta-Agonists; Animals; Calcimycin; Calcium Ionophores; Cardiovascular Diseases; Caveolin | 2021 |
Alpha-terpineol prevents myocardial damage against isoproterenol-MI induced in Wistar-Kyoto rats: new possible to promote cardiovascular integrity.
Topics: Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Cardiotoxicity; Cardiovascular Diseases; Cycl | 2022 |
Leonurine inhibits cardiomyocyte pyroptosis to attenuate cardiac fibrosis via the TGF-β/Smad2 signalling pathway.
Topics: Animals; Cardiovascular Diseases; Fibrosis; Isoproterenol; Myocytes, Cardiac; Pyroptosis; Rats; Sign | 2022 |
The Improvement of Functional State of Brain Mitochondria with Astaxanthin in Rats after Heart Failure.
Topics: Animals; Brain; Calcium; Cardiovascular Diseases; Heart Failure; Isoproterenol; Mitochondria; Mitoch | 2022 |
The effect of bempedoic acid an ATP-citrate lyase inhibitor on cardiovascular risk factors in rats with experimentally induced myocardial infarction and hyperlipidemia.
Topics: Adenosine Triphosphate; Animals; Cardiovascular Diseases; Cholesterol, LDL; Enzyme Inhibitors; Fatty | 2022 |
Sub-chronic lead exposure produces β
Topics: Animals; Arterial Pressure; Cardiovascular Diseases; Down-Regulation; Heart Rate; Hexamethonium; Hyp | 2017 |
Cardiovascular risk score is linked to subcutaneous adipocyte size and lipid metabolism.
Topics: Adipocytes; Adult; Age Factors; Atrial Natriuretic Factor; Body Mass Index; Body Weight; Cardiovascu | 2017 |
Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome.
Topics: Animals; Cardiovascular Diseases; Cells, Cultured; Disease Models, Animal; Drugs, Chinese Herbal; Fi | 2018 |
[Establishment of cardiac remodeling model in FVB/N mice by intraperitoneal injection of isoproterenol].
Topics: Animals; Atrial Remodeling; Cardiovascular Diseases; Collagen; Disease Models, Animal; Humans; Injec | 2018 |
Stimulation of β-adrenoceptors up-regulates cardiac expression of galectin-3 and BIM through the Hippo signalling pathway.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bcl-2-Like Protein 11; Cardiovascula | 2019 |
Beta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular disease.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Blood Glucose; Blood Pressure; Cardiovascular Dis | 2015 |
Effect of Cardiovascular Injury on Catabolism of Adenosine and Adenosine 5-'Triphosphate in Systemic Blood in a Freely Moving Rat Model In Vivo.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cardiova | 2016 |
Treatment with Rhus tripartita extract curtails isoproterenol-elicited cardiotoxicity and oxidative stress in rats.
Topics: Animals; Cardiovascular Diseases; Cell Line; Heart; Isoproterenol; Male; Myocardium; Oxidative Stres | 2016 |
Subjective social status predicts in vivo responsiveness of β-adrenergic receptors.
Topics: Adult; Biomarkers; Body Mass Index; Cardiovascular Diseases; Cardiovascular System; Ethnicity; Femal | 2012 |
Severe Adams-Stokes syndrome treated with isuprel and an artificial pacemaker.
Topics: Adams-Stokes Syndrome; Cardiovascular Diseases; Heart Block; Humans; Isoproterenol; Norepinephrine; | 1955 |
Quinidine intoxication treated by isoproterenol (Isuprel).
Topics: Cardiovascular Diseases; Humans; Isoproterenol; Quinidine; Sympathomimetics; Ventricular Fibrillatio | 1961 |
Effect of isoproterenol in digitalis cardiotoxicity.
Topics: Arrhythmias, Cardiac; Cardiotoxicity; Cardiovascular Diseases; Digitalis; Heart Block; Humans; Isopr | 1962 |
Isoproterenol-induced myocardial infarction in animals.
Topics: Animals; Cardiovascular Diseases; Isoproterenol; Myocardial Infarction; Sympathomimetics | 1962 |
[EFFECT OF ISOPROPYLARTERENOL ON ACUTE CARDIAC FAILURE FOLLOWED BY DIRECT VISION CARDIAC SURGERY].
Topics: Cardiac Surgical Procedures; Cardiovascular Diseases; Dogs; Heart Block; Heart Failure; Heart, Artif | 1964 |
VENTRICULAR FIBRILLATION.
Topics: Cardiovascular Diseases; Diphenhydramine; Drug Therapy; Electrocardiography; Humans; Isoproterenol; | 1964 |
[TREATMENT OF ATRIOVENTRICULAR BLOCK].
Topics: Adams-Stokes Syndrome; Atrioventricular Block; Cardiovascular Diseases; Drug Therapy; Epinephrine; H | 1965 |
THE COURSE OF HEALING OF EXPERIMENTAL MYOCARDIAL INFARCTION IN THE RAT.
Topics: Cardiovascular Diseases; Cicatrix; Isoproterenol; Myocardial Infarction; Pathology; Pharmacology; Ra | 1965 |
VENTRICULAR FIBRILLATION: A CASE OF SPONTANEOUS REVERSION.
Topics: Cardiovascular Diseases; Electrocardiography; Heart Massage; Humans; Isoproterenol; Ventricular Fibr | 1965 |
Unusual cause of partially reversible severe cardiovascular autonomic failure.
Topics: Autonomic Nervous System; Autonomic Nervous System Diseases; Cardiovascular Diseases; Cardiovascular | 2003 |
Mice lacking sulfonylurea receptor 2 (SUR2) ATP-sensitive potassium channels are resistant to acute cardiovascular stress.
Topics: Acute Disease; Adrenergic beta-Agonists; Animals; ATP-Binding Cassette Transporters; Calcium Channel | 2007 |
Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats.
Topics: Acetylcholine; Animals; Aorta; Blood Glucose; Cardiovascular Diseases; Cod Liver Oil; Diabetes Melli | 2007 |
Reduced beta 2-receptor mediated vasodilation in African Americans.
Topics: Adult; Black or African American; Blood Pressure; Cardiovascular Diseases; Dose-Response Relationshi | 1995 |
The pharmacokinetics of isoproterenol in critically ill pediatric patients.
Topics: Adolescent; Arrhythmias, Cardiac; Cardiovascular Diseases; Child; Child, Preschool; Critical Illness | 1993 |
Role of hypertension in ischemic heart disease and cerebral vascular disease in the cynomolgus monkey with coarctation of the aorta.
Topics: Animals; Aortic Coarctation; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Cerebral Arterie | 1977 |
Drugs used in the care of the cardiac patient.
Topics: Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Atropine; Bretylium Tosylate; Cardiac | 1978 |
Neonatal and pediatric cardiovascular crises.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Bradycardia; Cardiovascular Diseases; Digoxin; Emerge | 1975 |
[Circulatory survival of irreversible comas].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anuria; Blood Transfusion; Blood Volume; Body Temperature; | 1975 |
The comparative study of cardiovascular toxins utilizing a sensitive indicator of sublethal toxic injury.
Topics: Allylamine; Amines; Aminopropionitrile; Animals; Aorta, Thoracic; Cardiovascular Diseases; Isoproter | 1987 |
Verapamil in cardiology.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Anura; Arrhythmi | 1974 |
Instrumented primates as cardiovascular models.
Topics: Acetylcholine; Animals; Blood Circulation; Blood Pressure Determination; Capillary Resistance; Cardi | 1974 |
Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Cardiovascular Diseases; Drug Antagonism; H | 1972 |
[Protective action of blocking of beta-1 adrenergic receptors against cardio-vascular complications in the course of treatment of bronchial asthma with sympathomimetic amines].
Topics: Adolescent; Adult; Aged; Asthma; Biogenic Amines; Cardiovascular Diseases; Female; Humans; Isoproter | 1973 |
[Treatment of rhythm disorders in early results of open heart surgery].
Topics: Acid-Base Equilibrium; Acidosis, Respiratory; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiovascu | 1969 |
The response of the cardiovascular system to sympathicomimetic drugs.
Topics: Blood Pressure; Cardiac Output; Cardiovascular Diseases; Epinephrine; Heart Rate; Hemodynamics; Huma | 1969 |
Bronchodilators.
Topics: Alcohols; Aminophylline; Asthma; Bronchodilator Agents; Cardiovascular Diseases; Child; Child, Presc | 1970 |
The pathogenesis and management of peripheral circulatory failure.
Topics: Arteries; Blood Pressure; Blood Transfusion; Blood Volume; Cardiac Output; Cardiovascular Diseases; | 1970 |
Pharmacodynamics and clinical use of cardiovascular drugs after cardiac surgery.
Topics: Anti-Arrhythmia Agents; Cardiac Output; Cardiac Surgical Procedures; Cardiovascular Diseases; Digita | 1970 |
[The use of isoprenaline in cardiovascular collapse].
Topics: Adult; Aged; Cardiovascular Diseases; Humans; Isoproterenol; Male; Middle Aged; Shock, Septic | 1967 |
[Studies on cardiovascular abnormalities in hyperthyroidism patients with special reference to adrenergic beta-receptor].
Topics: Adolescent; Adult; Cardiovascular Diseases; Hemodynamics; Humans; Hyperthyroidism; Isoproterenol; Mi | 1968 |
Increases beta-receptor responsiveness; central or peripheral?
Topics: Autonomic Nervous System; Cardiovascular Diseases; Chemoreceptor Cells; Hypertension; Isoproterenol; | 1969 |
Peripheral arterial insufficiency. A complication of beta-adrenergic blocking therapy.
Topics: Adult; Blood Circulation; Cardiovascular Diseases; Female; Heart Diseases; Humans; Hypertension; Hys | 1969 |